Considering that these results hinted that IL-1β production may be indicative of the host inflammatory condition, when compared to patients with other diseases (especially autoimmune diseases) [38], it is reasonable to expect that plasma IL-1β levels would be also higher in non-TB patients. This evidence concerns the gene IL1B and autoimmune disease.